• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION HANCOCK II MITRAL BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION HANCOCK II MITRAL BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number UNKNOWN
Device Problem Material Perforation (2205)
Patient Problems Calcium Deposits/Calcification (1758); Mitral Regurgitation (1964); Mitral Valve Stenosis (1965)
Event Date 01/01/2014
Event Type  Injury  
Event Description
Medtronic received information via literature review that a (b)(6) male patient underwent successful implant of a medtronic mitral bioprosthetic valve (model/serial not reported).Approximately 27 years postimplant, the patient presented with exertional dyspnea.Transthoracic echocardiography (tte) revealed moderate mitral stenosis and regurgitation.Transesophageal echocardiography (tee) showed moderate calcification on the leaflets, three mitral regurgitation jets, and a perforation with additional paravalvular defect.In a reoperation the mitral valve was explanted and successfully replaced with a medtronic ats mechanical prosthesis.No additional adverse patient effects were reported.Macroscopic examination of the explanted mitral prosthesis revealed a leaflet perforation.The article concluded highlighting the long-term durability of this valve in the mitral position.
 
Manufacturer Narrative
(b)(4).Title: very long-term durability of hancock ii porcine bioprosthesis on mitral position evaluation with real-time three-dimensional transesophageal echocardiography authors: cüneyt toprak, mehmet özkan, macit kalçik, sinan cersit, mehmet altug tuncer citation: arch turk soc cardiol 2014;42(5):497 (doi: 10.5543/tkda.2014.57418).(b)(4).
 
Manufacturer Narrative
Conclusion: no device was returned and no unique device identifier numbers were provided.Based on the available information a review of the device history record could not be performed and root cause could not be identified.
 
Event Description
Requests for additional information provided no further details.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HANCOCK II MITRAL BIOPROSTHETIC HEART VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC STRUCTURAL HEART
8200 coral sea street ne
mounds view MN 55112
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key4923785
MDR Text Key19643960
Report Number2025587-2015-00761
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeTU
PMA/PMN Number
P980043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,foreign,health profe
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 07/27/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNKNOWN
Device Catalogue NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 06/22/2015
Initial Date FDA Received07/18/2015
Supplement Dates Manufacturer Received07/27/2015
Supplement Dates FDA Received09/18/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age00057 YR
-
-